US Patent 10882898 Human immunodeficiency virus neutralizing antibodies
Patent 10882898 was granted and assigned to Gilead Sciences on January, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+174 characters)
Article
Patent abstract
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Brian A. Carr0
Craig S. Pace0
John Corbin0
Mini Balakrishnan0
Nathan D. Thomsen0
Xue Zhang0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
108828980
Date of Patent
January 5, 2021
0Patent Application Number
162737530
Date Filed
February 12, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
US Patent 10882898 Human immunodeficiency virus neutralizing antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10882898
Date of patent
January 5, 2021
Patent application number
16273753
Date Filed
February 12, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10882898 Human immunodeficiency virus neutralizing antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
